Drug Reactions Affecting Hair: Diagnosis

    April 2007 in “ Dermatologic Clinics
    Antonella Tosti, Massimiliano Pazzaglia
    Image of study
    TLDR Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.
    The 2007 document outlines how certain drugs can cause hair loss, changes in hair color and shape, and stimulate hair growth. Telogen effluvium, the most common drug-induced hair loss, involves excessive shedding and can be caused by various drugs, including anticoagulants and antineoplastic agents, with up to 50% of patients affected in some cases. Anagen effluvium, often due to cytotoxic drugs, can lead to severe hair loss, while cicatricial alopecia results in permanent thinning from follicle destruction. The document also describes permanent alopecia in patients undergoing bone marrow transplantation, and drug-induced lichen planopilaris, which may not respond to treatment. Hirsutism and hypertrichosis can be side effects of drugs with androgenic effects, with up to 50% of patients on high doses of Cyclosporin A affected. Prostaglandin analogs in eyedrops can cause eyelash changes, and topical minoxidil can lead to hypertrichosis, especially at higher concentrations. Diagnosis involves reviewing all drugs taken up to 4 months prior, and management may include drug discontinuation and treatments like finasteride or minoxidil. Scalp hypothermia and minoxidil are options for managing anticancer drug-induced hair loss, with the latter accelerating regrowth but not preventing loss.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results

    Related Community Posts Join

    6 / 594 results

      community The amazing fast pace of PP405.

      in Chat  322 upvotes 2 weeks ago
      PP405 is a new hair loss treatment advancing quickly in trials, generating excitement and skepticism about its effectiveness and marketing claims. Some see it as a potential alternative to minoxidil and finasteride, but concerns about long-term effects and the need for DHT blockers persist.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community Losing ground after 14 months of fin use and 11 months of min

      in Finasteride/Dutasteride  53 upvotes 3 years ago
      A 24-year-old person who is worried about their hair loss after 14 months of taking finasteride and 11 months of minoxidil. Replies to the post suggested sticking with their current regimen, that shedding from one part may not be telogen effluvium, and that shedding is normal with these drugs and they should evaluate in two to three months.

    Related Research

    6 / 6 results